Sigma Healthcare confirms early-stage talks to snap up Boots

Sigma Healthcare has confirmed it has held early-stage talks over a potential acquisition of Boots.
The Australian pharmaceutical wholesaler and retailer said it “continuously reviews opportunities” that could create shareholder value, but stressed there was no certainty that any deal would go ahead.
The confirmation followed a Financial Times report that Sigma was among potential bidders for Boots in a sale process that could value the British health and beauty retailer at about $1